Unique ID issued by UMIN | UMIN000019019 |
---|---|
Receipt number | R000021943 |
Scientific Title | Effects of Yogurt Drink containing AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Females |
Date of disclosure of the study information | 2015/09/16 |
Last modified on | 2019/12/23 11:57:29 |
Effects of Yogurt Drink containing AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Females
Effects of Yogurt Drink containing AVGP (Aloe Vera Gel Powder) for Skin Function
Effects of Yogurt Drink containing AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Females
Effects of Yogurt Drink containing AVGP (Aloe Vera Gel Powder) for Skin Function
Japan |
Skin Function
Not applicable | Adult |
Others
NO
This study aims to evaluate efficacy of Yogurt Drink containing AVGP (Aloe Vera Gel Powder) for skin function of healthy adult females
Efficacy
[1]Skin viscoelasticity
[2]Transepidermal water loss
[3]Water content of the skin
[4]Collagen score (measuring with ultrasonic waves)
[5]Wrinkles (corner of the eye)
[1]Observation for skin condition
[2]Subjective symptom for skin condition
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Oral ingestion of the test product (12 weeks)
Oral ingestion of the control product (12 weeks)
30 | years-old | <= |
60 | years-old | > |
Female
Healthy Japanese females aged 30-60 years
[1]Individuals who use regularly cosmetology or food affecting to skin condition
[2]Individuals who use cosmetics and creams except sunscreen on arm(s)
[3]Individuals whose face and arm(s) have an abnormality requiring treatment
[4]Individuals who contract allergic diseases with sleep deprivation or sleep disorder
[5]Individuals who have skin disease
[6]Individuals who excessively take alcohol
[7]Individuals who is a smoker (smoking over 20 cigarettes/day)
[8]Individuals who contract or have a history of serious skin disease, hepatopathy, kidney damage, heart disease, lung disease, endocrine disease, and metabolic disease
[9] Individuals who have a history of
drug allergy or serious food allergy
[10]Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period
[11]Individuals who participate in other clinical studies
[12]Individuals who have chronic constipation (defecation less than 3 times/week) in the past three months
[13]Individuals judged inappropriate for the study by the principal by the results of subject background, physical findings, or medical examination
64
1st name | Haruhi |
Middle name | |
Last name | Sugimura |
C'est la Vie Shimbashi Clinic
Medical office
105-0003
2-39-3 Nishishimbashi, Minato-ku, Tokyo
03-5408-8671
h-sugimura@shinkokai.jp
1st name | Eiji |
Middle name | |
Last name | Yoshikawa |
KSO Corporation
Sales department
105-0023
1-9-7 Shibaura, Minato-ku, Tokyo
03-3452-7733
yoshikawa@kso.co.jp
KSO Corporation
Morinaga Milk Industry co., Ltd.
Profit organization
Department of Dermatology, Wakayama Medical University
C'est la Vie Shimbashi Clinic Ethics Committee
2-39-3 Nishishimbashi, Minato-ku, Tokyo
03-5408-8671
h-sugimura@shinkokai.jp
NO
2015 | Year | 09 | Month | 16 | Day |
Published
64
2017 | Year | 01 | Month | 14 | Day |
Main results already published
2015 | Year | 07 | Month | 29 | Day |
2015 | Year | 07 | Month | 30 | Day |
2015 | Year | 09 | Month | 18 | Day |
2015 | Year | 12 | Month | 26 | Day |
2015 | Year | 09 | Month | 15 | Day |
2019 | Year | 12 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021943
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |